Site:Home > About JARI >> Company Introdution

     JARI Pharmaceutical Co., Ltd., founded in 2004 with a registered capital of 100 million RMB, is a high-tech enterprise specializing in R&D, manufacturing and sales of pharmaceutical intermediates, API and formulations, and belongs to the state key high-tech enterprise JARI Technology Group.

      There are two sites of JARI PHARMA, Songtiao and Dapu, covering an overall area of 150,000m2, with the constructions of office building, R&D center, production workshop, warehouse and supporting facilities. At present, our company can produce anti-cancer API, lyophilize powder for injection, tablets, hard capsules, small volume injections and non-anticancer API and intermediates.

      With an excellent R&D team and a competent management team, JARI PHARMA is one of the first pharmaceutical enterprises to pass the China new GMP certification. JARI PHARMA owns China GMP certificates, U.S. FDA cGMP certificates and PIC/S certificates and obtains dozens of patents and many honorary titles including "Jiangsu High-tech Enterprise", "Jiangsu Contract-abiding & Credit-abiding Enterprises", "Jiangsu Pilot Enterprises of Integration of Information and Industrialization", etc.

      With the first-class R&D system, advanced production system, complete quality management system and EHS system, JARI PHARMA is dedicated to providing high-quality drugs for the public.